Next Article in Journal
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic
Previous Article in Journal
Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d’Aosta Region, Italy, in the 2023–2024 Epidemic Season
 
 
Article

Article Versions Notes

Vaccines 2024, 12(5), 550; https://doi.org/10.3390/vaccines12050550
Action Date Notes Link
article xml file uploaded 17 May 2024 16:14 CEST Original file -
article xml uploaded. 17 May 2024 16:14 CEST Update -
article pdf uploaded. 17 May 2024 16:14 CEST Version of Record https://www.mdpi.com/2076-393X/12/5/550/pdf-vor
article html file updated 17 May 2024 16:15 CEST Original file -
article xml file uploaded 20 May 2024 08:16 CEST Update -
article xml uploaded. 20 May 2024 08:16 CEST Update https://www.mdpi.com/2076-393X/12/5/550/xml
article pdf uploaded. 20 May 2024 08:16 CEST Updated version of record https://www.mdpi.com/2076-393X/12/5/550/pdf
article html file updated 20 May 2024 08:19 CEST Update https://www.mdpi.com/2076-393X/12/5/550/html
Back to TopTop